|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Progressive Primary Sclerosing Cholangitis Requiring Liver Transplantation Is Associated With Reduced Need for Colectomy in Patients With Ulcerative Colitis显示文摘 | Udayakumar Navaneethan Preethi G.K. Venkatesh Saurabh Mukewar Bret A. Lashner Feza H. Remzi Arthur J. McCullough Ravi P. Kiran Bo Shen John J. Fung | 2012 | Clinical Gastroenterology and Hepatology2012，，5： | 2 |
| 2 | The impact of ursodeoxycholic acid on cancer,dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis显示文摘 | Wolf JM Rybicki LA Lashner BA | 2005 | Aliment Pharmacol Ther2005，22，9： | 1 |
| 3 | Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis 显示文摘 | Lashner BA | 1993 | J Cancer Res Clin On?col1993，119，9： | 1 |
| 4 | Intestinal adenocarcinoma in Crohn' s disease: a report of 30 cases with a focus on coexisting dysplasia 显示文摘 | Perras RE Lashner BA | 1999 | am J Surg Pathol1999，23，6： | 1 |
| 5 | Clinical approach to colonic ischemia ic colitis显示文摘 | Elder K Lashner B A Solaiman F | 2009 | Cleve Clin J Meal2009，76，7： | 1 |
| 6 | Dysplasia and cancer complicating strictures in ulcerative colitis显示文摘 | Bret A. Lashner MD MPH Bruce C. Turner David G. Bostwick MD Paul H. Frank MD Stephen B. Hanauer MD | 1990 | Digestive Diseases and Sciences1990，，3： | 1 |
| 7 | Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial显示文摘 | Stephan R. Targan Brian G. Feagan Richard N. Fedorak Bret A. Lashner Remo Panaccione Daniel H. Present Martina E. Spehlmann Paul J. Rutgeerts Zsolt Tulassay Miroslava Volfova Douglas C. Wolf Chito Hernandez Jeffrey Bornstein William J. Sandborn | 2007 | Gastroenterology2007，，： | 1 |
| 8 | An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: A randomized, controlled trial 显示文摘 | Seidner D L Lashner B A Brzezinski A | 2005 | Clinical Gastroenterology and Hepatology2005，3，4： | 1 |
| 9 | An oral supple mentenriched with fish oil,soluble fiber,and antioxidants for corticosteroid sparing in ulcerativ ecolitis:arandomized,controlled trial显示文摘 | SEIDNER D L LASHNER B A BRZEZINSKI A | 2005 | Clinical Gastroenterology and Hepatology2005，4，3： | 1 |
| 10 | Clinical approach to colonic ischemia显示文摘 | Elder K Lashner BA Al Solamam F | 2009 | Cleve Clin J Med2009，76，7： | 1 |
| 11 | Making the most of currently available bowel preparations for colonscopy显示文摘 | Atreja A Nepal S Lashner BA | | 0，，05： | 1 |
| 12 | Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial显示文摘 | Stephan R. Targan Brian G. Feagan Richard N. Fedorak Bret A. Lashner Remo Panaccione Daniel H. Present Martina E. Spehlmann Paul J. Rutgeerts Zsolt Tulassay Miroslava Volfova Douglas C. Wolf Chito Hernandez Jeffrey Bornstein William J. Sandborn | 2007 | Gastroenterology2007，，5： | 1 |
| 13 | An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis:A randomized, controlled trial 显示文摘 | SEIDNER D L LASHNER B A BRZEZINSKI A | 2005 | Clinical Gastroenterology and Hepatology2005，3，4： | 1 |
| 14 | Intestinal adenocarcinoma in Crohn's disease:a report of 30 cases with a focus on coexisting dysplasia显示文摘 | Sigel JE Petras RE Lashner BA | 1999 | Am J Surg Pathol1999，23，6： | 1 |
| 15 | Cytomegalovirus colitis complicating inflammatory bowel disease 显示文摘 | Kandiel A Lashner B | 2006 | Am J Gastroenterol2006，101，12： | 1 |
| 16 | Intestinal adenocarcinoma in Crohn's disease: a report of 30 cases with a focus in coexisting dysplasia显示文摘 | Petras RE Lashner BA | 1999 | Am Surg Pathol1999，23，： | 1 |
| 17 | The risk of cancer and dysplasia among ulcerative colitis pathient with primary sclerosing cholangitis显示文摘 | MARCHESA P LASHNER B A LAVERY I C | 1997 | Am J Gastroenterol1997，92，： | 1 |
| 18 | The impact of ur- sodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholan- gitis显示文摘 | Wolf JM Rybicki LA Lashner BA | 2005 | Aliment Pharmacol Ther2005，22，9： | 1 |
| 19 | The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis显示文摘 | Kirti Shetty Lisa Rybicki Aaron Brzezinski William D Carey Bret A Lashner | 1999 | The American Journal of Gastroenterology1999，，6： | 1 |
| 20 | Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis显示文摘 | Bret A. Lashner | 1993 | Journal of Cancer Research and Clinical Oncology1993，，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员